logo of Vida Therapeutics
Portfolio company

Vida Therapeutics Inc.

Details
Region
Prairies and West
Industry sector
Biotechnology
Investment year
2012
Fund
Diversified Portfolio
Learn More
Investor
Dominique Bélanger
Dominique Bélanger

Managing Partner

View profile
About the company

viDA Therapeutics is advancing first-in-class drugs based on inhibitors of the extracellular serine protease, Granzyme B, to treat autoimmune and chronic inflammatory diseases. The company is focused on advancing their lead candidate into the clinic.